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Abstract. 
 
We isolated two novel actin filament
(F-actin)Ðbinding proteins from rat brain and rat 3Y1 
fibroblast. They were splicing variants, and we named 
brain big one b-nexilin and fibroblast small one s-nexi-
lin. b-Nexilin purified from rat brain was a protein of 
656 amino acids (aa) with a calculated molecular weight 
of 78,392, whereas s-nexilin, encoded by the cDNA iso-
lated from rat 3Y1 cells by the reverse transcriptase-
PCR method, was a protein of 606 aa with a calculated 
molecular weight of 71,942. b-Nexilin had two F-actinÐ
binding domains (ABDs) at the NH
 
2
 
-terminal and mid-
dle regions, whereas s-nexilin had one ABD at the mid-
dle region because 64 aa residues were deleted and 14 
aa residues were inserted in the first NH
 
2
 
-terminal 
ABD of b-nexilin, and thereby the first ABD lost its ac-
tivity. b- and s-nexilins bound along the sides of F-actin, 
but only b-nexilin showed F-actin cross-linking activity. 
b-Nexilin was mainly expressed in brain and testis, 
whereas s-nexilin was mainly expressed in testis, spleen, 
and fibroblasts, such as rat 3Y1 and mouse Swiss 3T3 
cells, but neither b- nor s-nexilin was detected in liver, 
kidney, or cultured epithelial cells. An immunofluores-
cence microscopic study revealed that s-nexilin was 
colocalized with vinculin, talin, and paxillin at cellÐ
matrix adherens junction (AJ) and focal contacts, but 
not at cellÐcell AJ, in 3Y1 cells. Overexpressed b- and 
s-nexilins were localized at focal contacts but not at 
cellÐcell AJ. These results indicate that nexilin is a novel 
F-actinÐbinding protein localized at cellÐmatrix AJ.
Key words: actin-binding protein ¥ focal contact ¥ 
stress fiber ¥ adherens junction ¥ integrin
 
T
 
he
 
 actin filament (F-actin)
 
1
 
Ðassociated adherens junc-
tions (AJs) are subclassed into two types: cellÐmatrix
and cellÐcell AJs (Geiger et al., 1985). CellÐmatrix
AJ includes focal contacts, also referred to as focal adhe-
sions or adhesion plaques, which are the specialized struc-
tures at the ends of stress fibers, up to 10 
 
m
 
m in length and
0.5 
 
m
 
m in width (Abercrombie and Dunn, 1975; Izzard and
Lochner, 1976; Heath and Dunn, 1978). Originally, focal
contacts were described in living or fixed fibroblasts cul-
tured on glass or plastic (Abercrombie et al., 1971). Typi-
cal focal contacts are mainly developed in cultured cells
and are rarely found in the organism. However, since cul-
tured cells are amenable to microscopic and biochemical
analyses and can be experimentally manipulated, the focal
contacts in cultured cells have been extensively studied as
a model system for cellÐmatrix AJ. A transmembrane con-
nection between the actin cytoskeleton and the extracellu-
lar matrix through the integrin family occurs at these sites
of the plasma membrane (Schwartz et al., 1995). At the ex-
tracellular surface, integrin interacts with matrix proteins,
whereas the cytoplasmic domain interacts directly or indi-
rectly with F-actinÐbinding proteins, including 
 
a
 
-actinin,
vinculin, and talin (Jockusch et al., 1995; Burridge and
Chrzanowska-Wodnicka, 1996). Moreover, a number of
structural and regulatory proteins, such as paxillin (Turner
et al., 1990), tensin (Wilkins et al., 1986; Lo et al., 1994;
Chuang et al., 1995), zyxin (Beckerle, 1986; Crawford and
Beckerle, 1991), profilin (Carlsson et al., 1977), gelsolin
(Wang et al., 1984), and FAK (Schaller et al., 1992), have
been identified and characterized. Most of these proteins
are found not only at cellÐmatrix AJ but also at cellÐcell
AJ, but paxillin and talin are restricted to cellÐmatrix AJ
(Geiger et al., 1985; Tidball et al., 1986; Drenkhahn et al.,
1988; Turner et al., 1990).
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Molecular linkage between the actin cytoskeleton and
the plasma membrane at cellÐcell AJ has also extensively
been investigated (Geiger, 1983, 1989; Geiger and Gins-
berg, 1991; Turner and Burridge, 1991; Luna and Hitt,
1992; Tsukita et al., 1992, 1997; Bretscher, 1993). Many
linker proteins have been isolated and characterized at
cellÐcell AJ, where cadherins interact with each other at
the extracellular surface (Takeichi, 1988, 1991; Geiger and
Ginsberg, 1991; Tsukita et al., 1992). At the cytoplasmic
surface, cadherin is associated with 
 
a
 
-, 
 
b
 
-, and 
 
g
 
-catenins
(Ozawa et al., 1989; Nagafuchi et al., 1991; Takeichi, 1991;
Tsukita et al., 1992). 
 
a
 
-Catenin directly interacts with F-actin
and indirectly interacts with F-actin through 
 
a
 
-actinin and/
or ZO-1 (Knudsen et al., 1995; Rimm et al., 1995; Itoh et
al., 1997). Thus, many F-actinÐbinding proteins appear to
link the actin cytoskeleton to the plasma membrane and
have important roles in the dynamic regulation of both
cellÐmatrix and cellÐcell AJ.
In contrast to cadherin-based cellÐcell AJ in epithelial
and endothelial cells, the molecular mechanism of synaptic
junction has not fully been understood, although recent
studies have revealed that cadherin is concentrated at syn-
aptic junctions (Fannon and Colman, 1996; Uchida et al.,
1996). To identify F-actinÐbinding proteins, which regu-
late synaptic junctions, we have been attempting to isolate
novel F-actinÐbinding proteins from rat brain using a blot
overlay method with 
 
125
 
I-labeled F-actin. We had isolated
and reported four novel F-actinÐbinding proteins: neura-
bin-I (Nakanishi et al., 1997), neurabin-II (Satoh et al.,
1998), afadin (Mandai et al., 1997), and frabin (Obaishi et
al., 1998). Neurabin-I is an F-actinÐbinding protein specifi-
cally expressed in neural tissue and is implicated in both
neurite formation and maintenance of synaptic junction
(Nakanishi et al., 1997). Neurabin-II is an F-actinÐbinding
protein ubiquitously expressed (Satoh et al., 1998). Neura-
bin-II is enriched at the postsynaptic density fraction in rat
brain and the cellÐcell AJ fraction in rat liver. Neurabin-II
is identical to the recently reported protein phosphatase
1Ðbinding protein, named spinophilin (Allen et al., 1997).
Afadin has two splicing variants: l-afadin ubiquitously ex-
pressed and s-afadin mainly expressed in neural tissue.
s-Afadin lacks the F-actinÐbinding domain. l-Afadin is lo-
calized at cellÐcell AJ. Frabin shows a homology to FGD1,
which has been identified to be the genetic locus responsi-
ble for faciogenital dysplasia (Pasteris et al., 1994). Frabin
is capable of inducing filopodium formation and c-Jun
NH
 
2
 
-terminal kinase activation as described for FGD1
(Zheng et al., 1996).
During the purification of these F-actinÐbinding pro-
teins, we purified the fifth F-actinÐbinding protein from
rat brain, which was localized at cellÐmatrix AJ. It has two
splicing variants that have different physical and func-
tional properties. We named big and small ones b- and
s-nexilins, respectively, from a Latin word nexilis meaning
Òbound together.Ó We describe here these novel F-actinÐ
binding proteins.
 
Materials and Methods
 
125
 
I-Labeled F-Actin Blot Overlay
 
125
 
I-labeled F-actin blot overlay was done as described (Chia et al., 1991;
Pestonjamasp et al., 1995). In brief, purified actin monomer (G-actin) was
labeled with 
 
125
 
IÐBolton Hunter reagent. 
 
125
 
I-labeled G-actin (1 mg/ml;
average specific activity, 63.3 
 
m
 
Ci/mg) was polymerized with 18 
 
m
 
g/ml of
gelsolin (Sigma Chemical Co., St. Louis, MO) (molar ratio 100:1) by incu-
bation at 4
 
8
 
C for 10 min in a solution containing 20 mM Pipes at pH 7.0, 50
mM KCl, and 2 mM MgCl
 
2
 
. Phalloidin was then added to give a final con-
centration of 40 
 
m
 
M. The mixture was then incubated at room tempera-
ture for another 15 min and stored at 4
 
8
 
C as 
 
125
 
I-labeled F-actin. The sam-
ple to be tested was subjected to SDS-PAGE and transferred to a
nitrocellulose membrane. The membrane was blocked in TBS containing
5% defatted powder milk. The membrane was then incubated at room
temperature for 1 h with 10 
 
m
 
g/ml of 
 
125
 
I-labeled F-actin in TBS contain-
ing 5% defatted powder milk and 4 
 
m
 
M phalloidin. After the incubation,
the membrane was washed with TBS containing 0.5% Tween 20, followed
by autoradiography using an image analyzer (Fujix BAS-2000; Fuji Photo
Film Co., Tokyo, Japan).
For competition experiments, 
 
125
 
I-labeled F-actin was prepared as de-
scribed. 10 
 
m
 
g/ml of 
 
125
 
I-labeled F-actin was incubated at room tempera-
ture for 30 min with 0.66 mg/ml of myosin subfragment 1 (S1) (Sigma
Chemical Co.) in a solution containing 20 mM Pipes at pH 7.0, 58 mM
KCl, 2 mM MgCl
 
2
 
, 130 
 
m
 
M CaCl
 
2
 
, and 0.4 
 
m
 
M phalloidin. Where indi-
cated, 4 mM MgATP was added to the mixture. After the incubation, the
mixture was diluted with an equal volume of TBS containing 0.5% Tween
20 and 10% defatted powder milk, and it was added to the blot mem-
brane, followed by incubation at room temperature for 1 h.
 
Purification of b-Nexilin
 
The synaptic soluble fraction was prepared from 480 adult rat brains as
described (Mizoguchi et al., 1990) and stored at 
 
2
 
80
 
8
 
C until use. 1/12 of
the fraction (420 ml, 360 mg of protein) was adjusted to 0.2 M NaCl with
4 M NaCl and applied to a Q-Sepharose FF column (2.6 
 
3 
 
10 cm; Amer-
sham Pharmacia Biotech, Piscataway, NJ) equilibrated with buffer A (20
mM Tris-Cl at pH 7.5 and 1 mM DTT) containing 0.2 M NaCl. After the
column was washed with 250 ml of buffer A containing 0.2 M NaCl, elu-
tion was performed with 350 ml of buffer A containing 0.5 M NaCl at a
flow rate of 5 ml/min. Fractions of 10 ml each were collected. b-Nexilin ap-
peared in fractions 5Ð19. These fractions (150 ml, 152 mg of protein) were
collected, and NaCl was added to give a final concentration of 2 M. The
sample was applied to a phenyl-Sepharose column (2.6 
 
3 
 
10 cm; Amer-
sham Pharmacia Biotech) equilibrated with buffer A containing 2 M
NaCl. After the column was washed with 250 ml of the same buffer, elu-
tion was performed with a 360-ml linear gradient of NaCl (2.0Ð0 M) in
buffer A, followed by 180 ml of buffer A, at a flow rate of 3 ml/min. Frac-
tions of 6 ml each were collected. b-Nexilin appeared in fractions 45Ð49.
The active fractions (30 ml, 3.7 mg of protein) were collected. The two
samples were combined and applied to a phenyl-5PW RP column (0.75 
 
3
 
7.5 cm; Tosoh, Tokyo, Japan) equilibrated with 0.05% trifluoroacetic acid.
Elution was performed with a 320-ml linear gradient of acetonitrile (10Ð
80%) in 0.05% trifluoroacetic acid. Fractions of 1.33 ml each were col-
lected. b-Nexilin appeared in fractions 44 and 45. The active fractions of
the six phenyl-5PW RP column chromatographies (7.98 ml, 40 
 
m
 
g of pro-
tein) were collected, lyophilized, and stored at 
 
2
 
80
 
8
 
C.
 
Determination of Partial Amino Acid Sequence
of b-Nexilin
 
The purified phenyl-5PW RP sample (40 
 
m
 
g of protein) was subjected to
SDS-PAGE (8% polyacrylamide gel). A protein band corresponding to
b-nexilin was cut out from the gel and digested with a lysyl endopeptidase,
and the digested peptides were separated by TSKgel ODS-80Ts (4.6 
 
3
 
150 mm; Tosoh) reverse-phase high-pressure liquid column chromatogra-
phy as described (Imazumi et al., 1994). The amino acid (aa) sequences of
the eight peptides were determined with a peptide sequencer.
 
Molecular Cloning of b- and s-Nexilins
 
Computer homology search revealed that two of the eight peptides were
contained within a peptide sequence deduced from the cDNA fragment
isolated from a human cDNA library (Elisei et al., 1993). Therefore, a
probe was obtained by the PCR method with oligonucleotide primers
from the cDNA fragment. To obtain full-length b-nexilin, a rat brain
cDNA library in 
 
l
 
ZAPII (Stratagene, La Jolla, CA) was screened using
the probe.
Reverse transcriptaseÐPCR was performed to amplify a fragment of 
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mRNA encoding s-nexilin expressed in 3Y1 cells. For that purpose, total
RNA was prepared from 3Y1 cells using the ISOGEN RNA extraction kit
(Nippon Gene, Tokyo, Japan). Reverse transcription of 0.5 
 
m
 
g of total
RNA was carried out using Ready-To-Go You-Prime First-Strand Beads
and pd(N)6 (Amersham Pharmacia Biotech). For PCR, an aliquot of
cDNA was amplified using primers based on the NH
 
2
 
- and COOH-termi-
nal regions of b-nexilin. The primer sequences were 5
 
9
 
-atgaatgacgtgtcaca-
gaaggca-3
 
9
 
 and 5
 
9
 
-ctagtagtcatccatttcaatggt-3
 
9
 
 for the NH
 
2
 
- and COOH-
terminal regions, respectively. DNA sequencing was performed by the
dideoxy nucleotide termination method using a DNA sequencer (ALF ex-
press; Amersham Pharmacia Biotech). For coiled-coil prediction, the
PAIRCOIL program was used (Berger et al., 1995).
 
Expression and Purification of Recombinant
b- and s-Nexilins
 
Prokaryotic and eukaryotic expression vectors were constructed in pGEX
(Amersham Pharmacia Biotech), pCMV5 (Takeuchi et al., 1997), pCIneo
(Promega Corp., Madison, WI), and pRSET (Invitrogen Corp., Carlsbad,
CA) using standard molecular biological methods (Sambrook et al., 1989).
Glutathione S-transferase (GST) fusion constructs of b- and s-nexilins
contained the following amino acid (aa) residues: pGEX-b-nexilin-1, aa
1Ð150; pGEX-b-nexilin-1
 
9
 
, aa 1Ð240; pGEX-b-nexilin-2, aa 77Ð240;
pGEX-b-nexilin-3, aa 151Ð283; pGEX-b-nexilin-4, aa 211Ð330; pGEX-
b-nexilin-5, aa 284Ð450; pGEX-b-nexilin-6, aa 493Ð656; pGEX-s-nexilin-1,
aa 1Ð100; and pGEX-s-nexilin-1
 
9
 
, aa 1Ð190. The GST fusion proteins were
purified by use of glutathione-Sepharose beads according to the manufac-
turerÕs protocol (Amersham Pharmacia Biotech). Full-length b- and s-nex-
ilins were constructed in pCMV5 and pRSET vectors. Full-length and
various truncated mutants of b- and s-nexilins were constructed in pCI-
neo-myc vector. pCIneo-myc vector was constructed by ligating the oligo-
nucleotides, 5
 
9
 
-ctagaccccccaacatggagcagaagcttatcagcgaggaggacctgctcgagg-3
 
9
 
/
5
 
9
 
-aattctcgagcaggtcctcctcgctgataagcttctgctccatgttggggggt-3
 
9
 
, into the NheI
and EcoRI sites of pCIneo. The myc-epitope (MEQKLISEEDL) was in-
serted at the NH
 
2
 
 termini of full-length b- and s-nexilins. Various myc-
tagged truncated mutants of b- and s-nexilins contained the following aa
residues: pCIneo-myc-s-nexilin-M1, aa 1Ð100; pCIneo-myc-s-nexilin-M2,
aa 1Ð233; pCIneo-myc-FC, aa 161Ð430 for b-nexilin, aa 211Ð480 for b-nex-
ilin; pCIneo-myc-ABD, aa 234Ð400 for s-nexilin, aa 284-450 for b-nexilin;
pCIneo-myc-CC, aa 101Ð233 for s-nexilin, aa 151Ð283 for b-nexilin; pCI-
neo-myc-b-nexilin-ABD, aa 1Ð150; and pCIneo-myc-b-nexilin-M1, aa 1Ð283.
pRSET was designed to express the proteins with the NH
 
2
 
-terminal six
histidine residues (His6). The His6-tagged proteins were purified by use
of TALON metal affinity beads according to the manufacturerÕs protocol
(CLONTECH Labs, Palo Alto, CA).
 
Assay for Cosedimentation of b- and s-Nexilins
with F-Actin
 
G-actin was polymerized by incubation at room temperature for 30 min in
a polymerization buffer (20 mM imidazole/Cl at pH 7.0, 2 mM MgCl
 
2
 
, 1
mM ATP, 0.5 mM DTT, and 90 mM KCl). His6-b- or His6-s-nexilin in an
indicated amount was incubated at room temperature for 30 min with 0.3
mg/ml of F-actin in a solution containing 25 mM imidazole/Cl at pH 7.0, 2
mM MgCl
 
2
 
, 1 mM ATP, 0.05 mM DTT, 27 mM KCl, and 100 mM NaCl,
and the mixture (50 
 
m
 
l) was placed over a 50-
 
m
 
l cushion of 30% sucrose in
the polymerization buffer. To estimate 
 
K
 
d
 
 values, various amounts of
His6-b- or His6-s-nexilin were incubated with 0.1 mg/ml of F-actin in a so-
lution containing 32 mM imidazole/Cl at pH 7.0, 2 mM MgCl
 
2
 
, 1 mM ATP,
0.05 mM DTT, 27 mM KCl, and 100 mM NaCl. After the sample was cen-
trifuged at 130,000 
 
g
 
 for 20 min, the supernatant was removed from the
cushion and the pellet was brought to the original volume in an SDS sam-
ple buffer. The comparable amounts of the supernatant and pellet frac-
tions were subjected to SDS-PAGE, followed by protein staining with
Coomassie brilliant blue to quantitate recombinant b- and s-nexilins
cosedimented with F-actin using a densitometer.
For the cosedimentation assay using the crude samples, the cell lysates
of 
 
Escherichia coli 
 
expressing the GST fusion proteins of nexilin were cen-
trifuged at 100,000 
 
g
 
 for 1 h, and the supernatant was used for the assay. In
brief, after G-actin was polymerized as described above, the supernatant
(5 
 
m
 
l each) of the lysates was incubated at room temperature for 30 min
with 0.3 mg/ml of F-actin in a solution containing 25 mM imidazole/Cl at
pH 7.0, 2 mM MgCl
 
2
 
, 1 mM ATP, 0.05 mM DTT, 27 mM KCl, and 100
mM NaCl, and the mixture (50 
 
m
 
l) was placed over a 50-
 
m
 
l cushion of 30%
sucrose in the polymerization buffer. After the sample was centrifuged at
130,000 
 
g
 
 for 20 min, the supernatant and pellet were subjected to SDS-
PAGE, followed by Western blot analysis using the anti-GST and antiac-
tin antibodies.
 
Assay for F-Actin Cross-linking Activity of
b- and s-Nexilins
 
Electron microscopy was performed as described (Endo and Masaki,
1982; Kato et al., 1996). In brief, 0.28 mg/ml of G-actin was incubated at
25
 
8
 
C for 45 min with His6-b- (40 
 
m
 
g/ml of protein) or His6-s-nexilin (37
 
m
 
g/ml of protein) in a solution containing 25 mM imidazole/Cl at pH 7.0,
140 mM NaCl, 2 mM MgCl
 
2
 
, 0.1 mM ATP, and 1 mM EGTA. The sam-
ples were negatively stained with 2% uranyl acetate and viewed with an
electron microscope (model H-7100; Hitachi, Tokyo, Japan).
Low shear viscometry was performed as described (Pollard and Coo-
per, 1982; Kato et al., 1996). In brief, His6-b- or His6-s-nexilin in an indi-
cated amount was mixed with 0.28 mg/ml of G-actin in a solution contain-
ing 20 mM imidazole/Cl at pH 7.0, 140 mM NaCl, 0.1 mM ATP, 0.5 mM
DTT, and 1 mM EGTA, and the solution was sucked into a 0.1-ml mi-
cropipette. After the incubation at 25
 
8
 
C for 35 min, the time for a stainless
ball to fall a fixed distance in the pipette was measured.
 
Cell Culture and Transfection
 
Rat 3Y1 and mouse mammary tumor MTD-1A cells were kindly supplied
by Dr. Sh. Tsukita (Kyoto University, Kyoto, Japan). MDCK cells were
supplied by Dr. W. Birchmeier (Max-Delbruck-Center for Molecular
Medicine, Berlin, Germany). These cells were maintained in DME con-
taining 10% FCS (GIBCO BRL; Life Technologies, Grand Island, NY),
penicillin (100 U/ml), and streptomycin (100 mg/ml). Transfection of pCI-
neo-myc-b- or pCIneo-myc-s-nexilin into 3Y1 cells was carried out using
LipofectAMINE reagent (GIBCO BRL). Transfection of pCMV-b- or
pCMV-s-nexilin into COS7 cells was carried out using the DEAE-dextran
method (Hata and Sdhof, 1995).
 
Antibodies and Immunofluorescence Staining
 
A rabbit polyclonal antibody against b-nexilin was raised against GST-
b-nexilin-4 (aa 211Ð330, the antinexilin antibody). The antiserum was affin-
ity-purified with the GST fusion protein covalently coupled to NHS-acti-
vated Sepharose (Amersham Pharmacia Biotech). The specificity of this
antibody was confirmed by Western blot analysis of the pCMV-b-nexilinÐ
transfected COS7 cells versus mock cells. Hybridoma cells expressing the
mouse monoclonal anti-myc antibody (9E10) were purchased from Amer-
ican Type Culture Collection (Rockville, MD). The rabbit monoclonal an-
tiactin antibody was purchased from Amersham Pharmacia Biotech. The
mouse monoclonal antipaxillin antibody was purchased from Transduc-
tion Laboratories (Lexington, KY). The mouse monoclonal antivinculin
and antitalin antibodies were purchased from Sigma Chemical Co. The
mouse monoclonal anti-GST antibody was purchased from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA). Rhodamine-phalloidin was pur-
chased from Molecular Probes, Inc. (Eugene, OR). The rat monoclonal
antiÐE-cadherin and antiÐP-cadherin antibodies were purchased from
TAKARA shuzo, Inc. (Shiga, Japan). Second antibodies for immunofluo-
rescence microscopy were obtained from Chemicon International, Inc.
(Temecula, CA).
For localization of s-nexilin and other marker proteins in 3Y1 cells, im-
munofluorescence microscopy was performed as described (Kotani et al.,
1997). In brief, the cells were fixed in 3.7% formaldehyde in PBS for 20
min. The fixed cells were incubated with 50 mM NH
 
4
 
Cl in PBS for 10 min
and permeabilized with PBS containing 0.2% Triton X-100 for 10 min. Af-
ter being soaked in 10% FCS/PBS for 30 min, the cells were treated with
the first antibody in 10% FCS/PBS for 1 h. The cells were then washed
with PBS three times, followed by incubation with the second antibody in
10% FCS/PBS for 1 h. For the detection of F-actin, rhodamine-phalloidin
was mixed with the second antibody solution. After being washed with
PBS three times, the cells were examined using a confocal laser scanning
microscope (model LSM 410; Carl Zeiss, Oberkochen, Germany).
 
Other Procedures
 
G-actin was purified from rabbit skeletal muscle as described (Pardee and
Spudich, 1982). Protein concentrations were determined with BSA as a
reference protein (Bradford, 1976). SDS-PAGE was performed as de-
scribed (Laemmli, 1970). Protein markers used were either myosin (200 
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kD), 
 
b
 
-galactosidase (116 kD), phosphorylase b (97 kD), BSA (66 kD),
and ovalbumin (45 kD), or myosin (206 kD), 
 
b
 
-galactosidase (117 kD),
BSA (89 kD), and ovalbumin (47 kD).
 
Results
 
Purification of b-Nexilin and Molecular Cloning of
Its cDNA
 
During the purification of neurabin-I, -II, afadin, and
frabin from rat brain using a blot overlay method with 
 
125
 
I-
labeled F-actin (Mandai et al., 1997; Nakanishi et al., 1997;
Obaishi et al., 1998; Satoh et al., 1998), we identified a
band of 
 
125
 
I-labeled F-actinÐbinding activity with a molec-
ular mass of about 97 kD (p97). p97 was highly purified by
column chromatographies, including Q-Sepharose, phe-
nyl-Sepharose, and phenyl-5PW RP column chromatogra-
phies. On the final phenyl-5PW RP column chromatogra-
phy, the F-actinÐbinding protein band closely coincided
with a protein with a molecular mass of 
 
z
 
97 kD, which
was identified by protein staining with Coomassie brilliant
blue (Fig. 1).
When the peptide mapping of the phenyl-5PW RP sam-
ple of p97 was performed, over 20 peptides were observed.
Of these peptides, the aa sequences of the eight peptides
were determined. Computer homology search revealed
that two of the eight peptides were contained within a pep-
tide sequence deduced from the cDNA fragment (se-
quence data available from GenBank/EMBL/DDBJ un-
der accession number S67069) isolated from a human
cDNA library (Elisei et al., 1993). Therefore, using a
probe obtained by the PCR method with oligonucleotide
Figure 1. Phenyl-5PW RP column chromatography. (A) Absor-
bance at 280 nm (A280). (B) 125I-labeled F-actin blot overlay. An
aliquot (33 ml) of each fraction was subjected to SDS-PAGE (8%
polyacrylamide gel), followed by 125I-labeled F-actin blot overlay.
(C) Protein staining with Coomassie brilliant blue. An aliquot
(200 ml) of each fraction was subjected to SDS-PAGE (8% poly-
acrylamide gel), followed by protein staining with Coomassie
brilliant blue. Arrowhead indicates p97 (b-nexilin).
Figure 2. Deduced amino acid sequences of b- and s-nexilins. (A)
Deduced aa sequence of b-nexilin. The aa sequences of the eight
peptide peaks derived from the purified sample of b-nexilin are
indicated by underlining. (B) Aligned sequences of b- and s-nexi-
lins. The deletion and insertion are indicated by a box and black
shading, respectively. These sequence data are available from
GenBank/EMBL/DDBJ under accession numbers AF056034 for
b-nexilin and AF056035 for s-nexilin. 
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primers from the cDNA fragment, we isolated several
clones from a rat brain cDNA library and obtained a full-
length clone by connecting two clones among them. The
encoded protein consisted of 656 aa and showed a calcu-
lated molecular weight of 78,392 (Fig. 2 
 
A
 
). It included all
the aa sequences of the eight peptides. The molecular
mass value calculated from the predicted aa sequence was
slightly less than that estimated by SDS-PAGE. To con-
firm whether this clone encoded a full-length cDNA of
p97, we constructed the eukaryotic expression vector with
this cDNA and expressed the protein in COS7 cells. West-
ern blot analysis indicated that the expressed protein
showed a mobility similar to that of native p97 on SDS-
PAGE (Fig. 3 
 
Aa
 
). Although the reason for the slight dif-
ference between the molecular mass value calculated from
the predicted aa sequence and that estimated by SDS-
PAGE was not known, we concluded that this clone en-
coded the full-length cDNA of p97.
We named p97 b-nexilin since p97 was the bigger of the
two splicing variants described below. To determine the
F-actinÐbinding domain of b-nexilin, we prepared the fu-
sion proteins of several truncated forms of b-nexilin with
GST and examined the binding of 
 
125
 
I-labeled F-actin to
these fusion proteins. Under the conditions where full-
length His6-b-nexilin showed 
 
125
 
I-labeled F-actinÐbinding
activity, GST-b-nexilin-1 (aa 1Ð150) and GST-b-nexilin-5
(aa 284Ð450) showed activity, whereas the other truncated
forms of b-nexilin did not show activity (Fig. 3 
 
Ba
 
). This
result suggests that b-nexilin has two F-actinÐbinding do-
mains at the NH
 
2
 
-terminal (aa 1Ð150) and middle (aa 284Ð
450) regions, and that b-nexilin interacts with F-actin
through these domains (Fig. 3 
 
C
 
). This conclusion was sup-
ported by two other lines of evidence described below
(see Figs. 4 
 
Ea 
 
and
 
 
 
7). The two F-actinÐbinding domains
showed no significant homology to any known F-actinÐ
binding protein in current protein database. In addition to
the two F-actinÐbinding domains, b-nexilin had a sequence
stretch that had high probability of forming a predicted
coiled-coil structure (Fig. 3 
 
C
 
). The coiled-coil probability
of the sequence stretch at the middle region (aa 244Ð281)
was calculated to be 0.9Ð1.0 (data not shown). The NH
 
2-
and COOH-terminal regions of b-nexilin did not show any
tendency to form a coiled-coil structure.
Biochemical Properties of b-Nexilin
In addition to 125I-labeled F-actin blot overlay, the binding
of b-nexilin to F-actin was examined by cosedimentation
of b-nexilin with F-actin. When full-length His6-b-nexilin
was incubated with F-actin, followed by ultracentrifuga-
tion, His6-b-nexilin was recovered with F-actin in the pel-
let (Fig. 4 Aa). The stoichiometry of the binding of His6-
b-nexilin to actin was calculated to be one His6-b-nexilin
molecule per about nine actin molecules (Fig. 4 B). The Kd
value was calculated to be 8.0 6 0.1 3 1027 M. It was ex-
amined by competition experiments using myosin S1, a
well-characterized protein that binds along the sides of
F-actin (Rayment et al., 1993; Schrder et al., 1993), whether
b-nexilin bound along the sides of F-actin or at the ends.
The binding of His6-b-nexilin to 125I-labeled F-actin was
inhibited by an excessive amount of myosin S1 (Fig. 4 Ca).
This inhibition was reversed by the addition of MgATP
Figure 3. Molecular characterization of b- and s-nexilins. (A)
Western blot analysis of recombinant b- and s-nexilins. The
pCMV-b- or pCMV-s-nexilin was transfected into COS7 cells,
and the cell lysates were subjected to SDS-PAGE (8% polyacryl-
amide gel), followed by Western blot analysis using the antinexi-
lin antibody. Arrowheads indicate b- and s-nexilins. (Aa) b-Nexi-
lin and (Ab) s-nexilin. (B) 125I-labeled F-actinÐbinding activity of
various truncated forms of b- and s-nexilins. The purified pro-
teins (0.2 mg of protein each), except for GST-b-nexilin-1, were
subjected to SDS-PAGE (10% polyacrylamide gel), followed by
125I-labeled F-actin blot overlay. GST-b-nexilin-1 was recovered
in the inclusion bodies during the preparation of the supernatant
of the cell lysates, and thus an aliquot of the cell lysates was used
for the assay. GST-b-Nexilin-1, aa 1Ð150; GST-b-Nexilin-2, aa 77Ð
240; GST-b-Nexilin-3, aa 151Ð283; GST-b-Nexilin-4, aa 211Ð330;
GST-b-Nexilin-5, aa 284Ð450; GST-b-Nexilin-6, aa 493Ð656; and
GST-s-Nexilin-1, aa 1Ð100. (Ba) b-Nexilin and (Bb) s-nexilin. (C)
Schematic drawing of the structures of b- and s-nexilins. ABD,
F-actinÐbinding domain; CC, coiled-coil region.The Journal of Cell Biology, Volume 143, 1998 1232
because MgATP dissociates the actinÐmyosin complex
(Fraser et al., 1975). b-Nexilin increased the viscosity in a
dose-dependent manner, and at 1.0 mM, the viscosity be-
came unmeasurably high as estimated by the falling ball
method for low shear viscometry (Fig. 4 D). Preliminary
results from electron microscopy confirmed the cross-link-
ing activity of b-nexilin as demonstrated by low shear vis-
cometry (data not shown). All of these results suggest that
b-nexilin binds along the sides of F-actin and shows cross-
linking activity, presumably because of the two F-actinÐ
binding domains. We confirmed the F-actinÐbinding
domains of b-nexilin shown in Fig. 3 C by the cosedimen-
tation assay using the GST fusion proteins. The purified
samples of the GST fusion proteins having the F-actinÐ
binding domains were insoluble under several conditions
where full-length b- or s-nexilin was not (data not shown).
Therefore, we used the crude samples of E. coli (the su-
pernatant of the cell lysates) expressing the GST fusion
proteins. As to GST-b-nexilin-1 (aa 1Ð150) in Fig. 3 Ba,
because it was recovered in the inclusion bodies during the
preparation of the supernatant of the cell lysates, we used
another GST fusion protein, GST-b-nexilin-19 (aa 1Ð240)
for the assay. GST-b-nexilin-19 and GST-b-nexilin-5 (aa
284Ð450) were cosedimented with F-actin, whereas GST-
b-nexilin-6 (aa 493Ð656) was not (Fig. 4 Ea). GST and
GST-b-nexilin-3 (aa 151Ð283) were not cosedimented with
F-actin (data not shown). These reuslts are consistent with
those of Fig. 3 Ba and support the conclusion shown in Fig.
3 C that b-nexilin has two F-actinÐbinding domains at the
NH2-terminal and middle regions, and that b-nexilin inter-
acts with F-actin through these domains.
The molecular mass value of b-nexilin was estimated by
sucrose density gradient ultracentrifugation. On sucrose
density gradient ultracentrifugation, His6-b-nexilin ap-
Figure 4. Biochemical properties of b- and s-nexilins. (A) Cosedimentation of His6-b- and His6-s-nexilins with F-actin. His6-b- (6.5 mg
of protein) or His6-s-nexilin (6.0 mg of protein) was mixed with F-actin, followed by ultracentrifugation. S, supernatant; P, pellet. Ar-
rows indicate actin. Arrowheads indicate His6-b- and His6-s-nexilins. (Aa) His6-b-nexilin and (Ab) His6-s-nexilin. (B) Binding of His6-b-
and His6-s-nexilins to F-actin. Various amounts of His6-b- or His6-s-nexilin were mixed with F-actin, followed by ultracentrifugation.
Amounts of the free and bound His6-b- or His6-s-nexilin were calculated by determining the protein amounts from the supernatant and
pellet fractions with a densitometer. The values are means 6 SEM of three independent experiments. (Filled circles) His6-b-nexilin and
(open circles) His6-s-nexilin. (C) Inhibition by myosin S1 of the binding of His6-b- and His6-s-nexilins to 125I-labeled F-actin. His6-b- or
His6-s-nexilin (50 ng of protein each) was subjected to SDS-PAGE (8% polyacrylamide gel), followed by the blot overlay with 125I-
labeled F-actin pretreated with myosin S1 in the presence or absence of ATP. (Ca) His6-b-nexilin and (Cb) His6-s-nexilin. (D) F-actin
cross-linking activity of His6-b- and His6-s-nexilins estimated by low shear viscometry. (Filled circles) His6-b-nexilin and (open circles)
His6-s-nexilin. (E) Cosedimentation of various truncated forms of b- and s-nexilins having or lacking the F-actinÐbinding domains. The
supernatant (5 ml each) of the lysates of E. coli expressing the GST fusion proteins was mixed with F-actin. After the sample was centri-
fuged, the supernatant and pellet were subjected to SDS-PAGE (10% polyacrylamide gel), followed by Western blot analysis using the
anti-GST and antiactin antibodies. GST-b-Nexilin-19, aa 1Ð240; GST-b-Nexilin-5, aa 284Ð450; GST-b-Nexilin-6, aa 493Ð656; and GST-
s-Nexilin-19, aa 1Ð190. S, supernatant; P, pellet. Arrowheads indicate actin. (Ea) b-Nexilin and (Eb) s-nexilin.Ohtsuka et al. A Novel F-ActinÐbinding Protein at Focal Contact 1233
peared at a position corresponding to a molecular mass of
about 66 kD (S value, z4.4) (data not shown). Because the
molecular mass value of b-nexilin estimated by SDS-
PAGE is z97 kD, this result suggests that b-nexilin exists
as a monomer.
Tissue Distribution of b-Nexilin
Western blot analysis showed that the antinexilin antibody
recognized a protein band with a molecular mass of z97
kD in brain and testis and a protein band with a slightly
smaller size (z95 kD) in testis, spleen, and fibroblasts such
as rat 3Y1 and mouse Swiss 3T3 cells (Fig. 5). Neither a big
nor small protein was detected in liver, kidney, or epithe-
lial cells, such as MDCK and MTD-1A cells. Because liver
and kidney contain abundant epithelial cells, these results
suggest that nexilin is expressed in nonepithelial cells but
not in epithelial cells.
Molecular Cloning and Physical Properties of s-Nexilin
The results described above led us to speculate about the
existence of a smaller isoform or a smaller splicing variant
of b-nexilin. Therefore, we attempted to isolate it and
cloned a small splicing variant from 3Y1 cells by use of the
reverse transcriptase-PCR method. The encoded protein
had 606 aa and showed a calculated molecular weight of
71,942. The protein showed the aa sequence identical to
that of b-nexilin except that it had 64 aa deletion and 14 aa
insertion in the first F-actinÐbinding domain of b-nexilin
(Fig. 2 B). We therefore named this variant s-nexilin (a
small variant of nexilin). To confirm whether this clone en-
coded a full-length cDNA, we constructed the eukaryotic
expression vector with this cDNA and expressed the pro-
tein in COS7 cells. Western blot analysis indicated that the
expressed protein with a molecular mass of z95 kD
showed two bands with mobilities similar to those of the
two bands endogenously detected in 3Y1 cells (Fig. 3 Ab).
Although the reason for the slight difference between the
molecular mass value calculated from the predicted aa se-
quence and that estimated by SDS-PAGE was not known,
we concluded that this clone encoded the full-length
cDNA of s-nexilin. The reason for the presence of the two
bands on SDS-PAGE is not known, but the two bands
may be caused by posttranslational modifications, such as
phosphorylation.
To determine whether the NH2-terminal region of s-nex-
ilin still has its F-actinÐbinding activity, we prepared a
fusion protein of the truncated form of s-nexilin with GST
and examined the binding of 125I-labeled F-actin to this
protein. Under the conditions where full-length His6-s-nex-
ilin showed 125I-labeled F-actinÐbinding activity, GST-s-nex-
ilin-1 (aa 1Ð100) did not show activity (Fig. 3 Bb). This
result suggests that s-nexilin has only one F-actinÐbinding
domain at the middle region (aa 234Ð400), and that s-nexi-
lin interacts with F-actin through this domain (Fig. 3 C).
This conclusion was supported by two other lines of evi-
dence described below (see Figs. 4 Eb and 7).
The binding of s-nexilin to F-actin was examined by
cosedimentation of s-nexilin with F-actin. When full-
length His6-s-nexilin was incubated with F-actin, followed
by ultracentrifugation, His6-s-nexilin was recovered with
F-actin in the pellet (Fig. 4 Ab). The stoichiometry of the
binding of His6-s-nexilin to actin was calculated to be one
His6-s-nexilin molecule per about ten actin molecules
(Fig. 4 B). The Kd value was calculated to be 9.0 6 0.2 3
1027 M. s-Nexilin also bound along the sides of F-actin
(Fig. 4 Cb). However, s-nexilin did not increase the viscos-
ity estimated by the falling ball method (Fig. 4 D). Consis-
tently, preliminary results from electron microscopy indi-
cated that s-nexilin had no cross-linking activity (data not
shown).
We confirmed the F-actinÐbinding domain of s-nexilin
shown in Fig. 3 C. GST-s-nexilin-19 (aa 1Ð190) was not
cosedimented with F-actin (Fig. 4 Eb). This result is con-
sistent with that of Fig. 3 Bb and supports the conclusion
shown in Fig. 3 C that s-nexilin has only one F-actinÐbinding
domain at the middle region, and that s-nexilin interacts
with F-actin through this domain. Sucrose density gradient
ultracentrifugation analysis revealed that His6-s-nexilin
appeared at a position corresponding to a molecular mass
of z66 kD (S value, z4.4) (data not shown), suggesting
that s-nexilin exists as a monomer. All of these results sug-
gest that s-nexilin binds along the sides of F-actin but lacks
cross-linking activity, presumably because of one F-actinÐ
binding domain.
Localization of s-Nexilin in 3Y1 Cells
Since s-nexilin was expressed in 3Y1 cells, we examined
the localization of s-nexilin in 3Y1 cells. An immunofluo-
rescence microscopic study revealed that s-nexilin was lo-
calized at the ends of stress fibers, which are known to be
focal contacts (Fig. 6, A and B). To confirm localization of
s-nexilin at focal contacts, we compared the localization of
s-nexilin with those of vinculin, talin, and paxillin, which
are typical focal contact proteins and thereby known to be
good markers for cellÐmatrix AJ (Geiger, 1979; Burridge
and Connell, 1983; Turner et al., 1990). s-Nexilin was colo-
calized with vinculin, talin, and paxillin (Fig. 6, CÐH).
However, s-nexilin was not colocalized with P-cadherin,
which is known to be a marker for cellÐcell AJ (Itoh et al.,
Figure 5. Tissue distribution of b-nexilin. For preparation of cell
lysates, cells were harvested with a cell scraper and suspended in
PBS. After sonication, samples were treated with SDSÐsample
buffer. The homogenates of various rat tissues (25 mg of protein
each) and whole-cell lysates of various cell lines (50 mg of protein
each) were subjected to SDS-PAGE (8% polyacrylamide gel),
followed by Western blot analysis using the antinexilin antibody.The Journal of Cell Biology, Volume 143, 1998 1234
1991), in 3Y1 cells that were densely plated (Fig. 6, I and
J). These results indicate that s-nexilin is specifically local-
ized at focal contacts but not at cellÐcell AJ.
Localization of Overexpressed Full-Length and 
Truncated Mutants of b- and s-Nexilins in 3Y1 Cells
We examined whether exogenously expressed b- or s-nexi-
lin was localized at cellÐmatrix AJ in 3Y1 cells. s-Nexilin
was localized at focal contacts (Fig. 7, A, a and B, a).
b-Nexilin was also localized at focal contacts (data not
shown). Similar results were obtained in other cells, such
as mouse 3T3, MTD-1A, and MDCK cells (data not
shown). Neither b- nor s-nexilin was localized at cellÐcell
junctions in 3Y1 cells (data not shown). Even in the case of
epithelial cells with prominent cellÐcell junctions, such as
MTD-1A and MDCK cells, overexpressed b- and s-nex-
ilins were consistently localized at focal contacts but not at
cellÐcell junctions (data not shown). These results indicate
that both b- and s-nexilins have potential to be localized at
focal contacts.
To clarify focal contact-targeting and F-actinÐbinding
domains in intact cells, we examined which overexpressed
truncated mutant of nexilin was localized at focal contacts
or colocalized with endogenous F-actin in 3Y1 cells. Myc-
ABD and myc-b-nexilin-ABD, having only the second and
first F-actinÐbinding domains, respectively, were diffusely
distributed in the cytoplasm and were not colocalized with
F-actin (Fig. 7, A, e and g, and B, e and g). Myc-b-nexilin-
M1, having the first F-actinÐbinding domain plus the fol-
lowing predicted coiled-coil region, was colocalized with
F-actin at the cell periphery (Fig. 7, A, h and B, h). Myc-
FC, having the predicted coiled-coil region and the second
F-actinÐbinding domain, was colocalized with F-actin at
focal contacts (Fig. 7, A, d and B, d). Myc-CC, having only
the predicted coiled-coil region that was overlapped in
myc-b-nexilin-M1 and myc-FC, was diffusely distributed in
the cytoplasm (Fig. 7, A, f and B, f). Moreover, myc-s-nex-
ilin-M1, which lacked the first F-actinÐbinding domain,
and myc-s-nexilin-M2, which lacked the first F-actinÐbind-
ing domain but had the predicted coiled-coil region, were
also diffusely distributed in the cytoplasm (Fig. 7, A, b and
c, and B, b and c). These reuslts are consistent with those
of Fig. 3, Ba and Bb, and support the conclusion shown in
Fig. 3 C that b-nexilin has two F-actinÐbinding domains at
the NH2-terminal and middle regions, and that s-nexilin
has only one F-actinÐbinding domain at the middle region.
At present, we do not know why the myc-tagged mutants,
having only the F-actinÐbinding domains, are not colocal-
ized with F-actin in intact cells, but the mutants, having the
F-actinÐbinding domains plus the predicted coiled-coil re-
gion, are colocalized with F-actin. Moreover, these results
suggest that a focal contact-targeting domain is located at
the region containing both the predicted coiled-coil region
and the second F-actinÐbinding domain.
Discussion
We isolated and characterized here two novel F-actinÐ
binding proteins, which were likely splicing variants de-
rived from the same gene. We named the big and small
ones b- and s-nexilins, respectively. We have concluded
that both the proteins are real F-actinÐbinding proteins on
the basis of the following observations: (a) full-length b-
and s-nexilins showed 125I-labeled F-actinÐbinding activity;
(b) both full-length b- and s-nexilins were cosedimented
with F-actin; (c) full-length b-nexilin showed F-actin cross-
linking activity; and (d) when full-length b- or s-nexilin
was expressed in COS7 cells, both the proteins were colo-
calized with F-actin (data not shown).
Structural analysis of b- and s-nexilins showed that the
nucleotide sequence of the s-nexilin cDNA was identical
to that of the b-nexilin cDNA except for the two splicing
Figure 6. Colocalization of s-nexilin with vinculin, talin, and paxillin in 3Y1 cells. 3Y1 cells were doubly stained with the antinexilin an-
tibody and phalloidin for F-actin, the antinexilin and antivinculin antibodies, the antinexilin and antitalin antibodies, the antinexilin and
antipaxillin antibodies, or the antinexilin and antiÐP-cadherin antibodies. Arrows indicate P-cadherinÐpositive cellÐcell AJ. (A, C, E, G,
and I) s-Nexilin, (B) actin, (D) vinculin, (F) paxillin, (H) talin, and (J) P-cadherin. Bars, 50 mm.Ohtsuka et al. A Novel F-ActinÐbinding Protein at Focal Contact 1235
regions that were located in the first F-actinÐbinding do-
main of b-nexilin. Consequently, the NH2-terminal region
of s-nexilin lost F-actinÐbinding activity. Thus, the big vari-
ant of nexilin has two F-actinÐbinding domains, whereas
the small one has one F-actinÐbinding domain (Fig. 3 C).
Among many F-actinÐbinding proteins so far identified,
some variants lose the F-actinÐbinding domain. For in-
stance, BPAG1n, the neuronal splicing form, contains the
functional F-actinÐbinding domain at the NH2-terminal re-
gion but BPAG1e, which is mainly expressed in epidermis,
lacks the domain (Yang et al., 1996). l-Afadin also has the
F-actinÐbinding domain at the COOH-terminal region,
but s-afadin lacks this domain (Mandai et al., 1997).
Among many F-actinÐbinding proteins having F-actin
cross-linking activity, the members of the a-actinin/spec-
trin superfamily have most extensively been studied (Hart-
wig and Kwiatkowski, 1991; Matsudaira, 1991). Most of
them usually form oligomers by association at rod do-
mains and hence show F-actin cross-linking activity, but
the members of the fimbrin (plastin) subfamily show
F-actin  cross-linking activity without oligomerization
since they have two F-actinÐbinding domains in a single
Figure 7. Localization of
overexpressed full-length and
various truncated mutants of
b- and s-nexilins in 3Y1 cells.
(A) Constructions of trun-
cated mutants of b- and s-nex-
ilins.  Myc-s-Nexilin-M1, aa
1Ð100;  myc-s-Nexilin-M2, aa
1Ð233; myc-FC, aa 161Ð430
for s-nexilin, aa 211Ð480 for
b-nexilin; myc-ABD, aa 234Ð
400 for s-nexilin, aa 284Ð450
for b-nexilin; myc-CC, aa
101Ð233 for s-nexilin, aa 151Ð
283 for b-nexilin; myc-b-Nexi-
lin-ABD, aa 1Ð150; and myc-
b-Nexilin-M1, aa 1Ð283. aÐh
for each mutant correspond
to aÐh in B. (B) Localization
of full-length and various
truncated mutants of b- and
s-nexilins. 3Y1 cells tran-
siently expressing myc-
tagged truncated mutants of
b- or s-nexilin were doubly
stained with the anti-myc an-
tibody and phalloidin for
F-actin. Arrows indicate focal
contacts. Arrowheads indi-
cate the region at the cell pe-
riphery where myc-b-nexilin-
M1 is localized. Bars, 50 mm. The Journal of Cell Biology, Volume 143, 1998 1236
subunit (Bretscher and Weber, 1980; De Arruda et al.,
1990). We have shown here that b-nexilin, but not s-nex-
ilin, has F-actin cross-linking activity, although neither
b- nor s-nexilin forms a dimer or an oligomer as estimated
by sucrose density gradient ultracentrifugation. Therefore,
the structural property of b-nexilin is apparently similar to
that of the fimbrin subfamily, although there is no signif-
icant homology between the primary structures of the
F-actinÐbinding domains of b- and s-nexilins and those of
the a-actinin/spectrin superfamily.
In addition to the F-actinÐbinding domains, both b- and
s-nexilins have predicted coiled-coil structures that have
been identified in a variety of cytoskeleton proteins (Lu-
pas et al., 1991; Lupas, 1996). They typically form rodlike,
homodimeric, or heterodimeric structures. Moreover, we
have identified a focal contact-targeting domain that con-
tained the predicted coiled-coil region and the F-actinÐ
binding domain at the middle region. Although it is
unknown why these two regions are necessary for the tar-
geting of b- and s-nexilins to focal contacts, it could be
speculated that there is a focal contact-specific protein(s)
that interacts with the predicted coiled-coil region of nexi-
lin and that the interactions of nexilin with both this pro-
tein and F-actin are essential for its correct localization.
Furthermore, b- and s-nexilins show different tissue ex-
pression patterns. b-Nexilin is mainly expressed in brain
and testis, whereas s-nexilin is expressed in testis, spleen,
and fibroblasts. It may be noted that neither b- nor s-nexi-
lin is expressed in epithelial cells such as MTD-1A and
MDCK cells. Consistently, neither b- nor s-nexilin is ex-
pressed in rat tissues such as liver and kidney, where there
are abundant epithelial cells. At present, it is not known
why nexilin is not expressed in epithelial cells, but there
may be another isoform of nexilin that is specifically ex-
pressed in epithelial cells.
The subcellular distribution analysis of s-nexilin in 3Y1
cells indicates that it is localized at cellÐmatrix AJ, but not
at cellÐcell AJ. Consistently, overexpressed s-nexilin was
localized at the same area. Overexpressed b-nexilin was
also localized at cellÐmatrix AJ, suggesting that it is local-
ized there in brain and testis. Many F-actinÐbinding pro-
teins localized at cellÐmatrix AJ have been isolated and
characterized (Jockusch et al., 1995; Burridge and Chrza-
nowska-Wodnicka, 1996). However, only talin has been
shown to be specifically localized at cellÐmatrix AJ but not
at cellÐcell AJ (Geiger et al., 1985; Tidball et al., 1986;
Drenckhahn et al., 1988). Talin is expressed not only in
nonepithelial cells but also in epithelial cells (Philp et al.,
1990). Nexilin is the second F-actinÐbinding protein that is
specifically localized at cellÐmatrix AJ, but this protein is
expressed only in nonepithelial cells. Like other F-actinÐ
binding proteins, nexilin may also be involved in the link-
age between the actin cytoskeleton and cellÐmatrix AJ in
nonepithelial cells, but its precise role in this linkage re-
mains unknown.
It has been suggested that cellÐmatrix and cellÐcell AJs
represent signaling hot spots on the cell surface. For in-
stance, the initial interaction between transmembrane pro-
teins, such as integrins, and extracellular ligands has been
shown to turn on a cascade of several signal transduction
(Keely et al., 1998). However, little is known about the
mechanism by which signals at the cell surface are relayed
to the nucleus and vice versa. Recently, several proteins,
including c-abl (Lewis et al., 1996), ZO-1 (Gottardi et al.,
1996), zyxin (Nix and Beckerle, 1997), and b-catenin (Beh-
rens et al., 1996; Molennar et al., 1996), have been demon-
strated to reside both at AJ and in the nucleus. Interest-
ingly, the PSORT protein localization prediction program
(Nakai and Kanehisa, 1992) indicates that b- and s-nexilins
also partition in the nucleus since these two proteins have
the consensus sequences for nucleoplasmin-like nuclear
localization signals (Robbins et al., 1991) (data not shown).
In fact, we observed weak nuclear stainings in fibroblasts
as shown in Fig. 6. However, we have not yet succeeded in
demonstrating that transfected full-length b- or s-nexilin is
translocated into the nucleus (data not shown). The signif-
icance of these nuclear localization signals in a variety of
proteins that are localized at cellÐmatrix and/or cellÐcell
AJs, including nexilin, is currently unknown.
We thank Dr. W. Birchmeier for providing MDCK cells, Dr. Sh. Tsukita
for providing rat 3Y1 and MTD-1A cells, Dr. D.W. Russell (University of
Texas Southwestern Medical Center, Dallas, TX) for providing the
pCMV5 vector, and Dr. Y. Hata (Takai Biotimer Project, ERATO, Kobe,
Japan) for providing the pCIneo-myc vector. We also thank Drs. Sh. Tsu-
kita and M. Itoh (Kyoto University, Kyoto, Japan) and Drs. Y. Yoneda
and T. Tachibana (Osaka University, Osaka, Japan) for helpful discus-
sions. We are grateful to M. Tokunaga, M. Kinoshita, T. Inoue, Y. Ha-
yashi, and H. Nohara for their technical assistance.
The work performed at Osaka University Medical School was sup-
ported by grants-in-aid for Scientific Research and for Cancer Research
from the Ministry of Education, Science, Sports, and Culture, Japan
(1997), by grants-in-aid for Abnormalities in Hormone Receptor Mecha-
nisms and for Aging and Health from the Ministry of Health and Welfare,
Japan (1997), and by grants from the Human Frontier Science Program
(1997).
Received for publication 9 April 1998 and in revised form 21 September
1998.
References
Abercrombie, M., and G.A. Dunn. 1975. Adhesions of fibroblasts to substra-
tum during contact inhibition observed by interference reflection micros-
copy. Exp. Cell Res. 92:57Ð62.
Abercrombie, M., J.E. Heaysman, and S.M. Pegram. 1971. The locomotion of
fibroblasts in culture. Exp. Cell Res. 67:359Ð367.
Allen, P.B., C.C. Quimet, and P. Greengard. 1997. Spinophilin: a novel protein
phosphatase 1 binding protein localized to dendritic spines. Proc. Natl. Acad.
Sci. USA. 94:9956Ð9961.
Beckerle, M.C. 1986. Identification of a new protein localized at sites of cell-
substrate adhesion. J. Cell Biol. 103:1679Ð1687.
Behrens, J., J.P. von Kries, M. Khl, L. Bruhn, D. Wedlich, R. Grosschedl, and
W. Birchmeier. 1996. Functional interaction of b-catenin with the transcrip-
tion factor LEF-1. Nature. 382:638Ð642.
Berger, B., D.B. Wilson, E. Wolf, T. Tonchev, M. Milla, and P.S. Kim. 1995.
Predicting coiled coils by use of pairwise residue correlations. Proc. Natl.
Acad. Sci. USA. 92:8259Ð8263.
Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of mi-
crogram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem. 72:248Ð254.
Bretscher, A., and K. Weber. 1980. Fimbrin, a new microfilament-associated
protein present in microvilli and other cell surface structures. J. Cell Biol. 86:
335Ð340.
Bretscher, A. 1993. Microfilaments and membranes. Curr. Opin. Cell Biol.
5:653Ð660.
Burridge, K., and L. Connell. 1983. A new protein of adhesion plaques and ruf-
fling membranes. J. Cell Biol. 97:359Ð367.
Burridge, K., and M. Chrzanowska-Wodnicka. 1996. Focal adhesions, contrac-
tility, and signaling. Annu. Rev. Cell Dev. Biol. 12:463Ð518.
Carlsson, L., L.E. Nystrom, I. Sundkvist, F. Markey, and U. Lindberg. 1977. Ac-
tin polymerizability is influenced by profilin, a low molecular weight protein
in non-muscle cells. J. Mol. Biol. 115:465Ð483.
Chia, C.P., A.L. Hitt, and E.J. Luna. 1991. Direct binding of F-actin to ponticu-
lin, an integral plasma membrane glycoprotein. Cell Motil. Cytoskel. 18:164Ð
179.Ohtsuka et al. A Novel F-ActinÐbinding Protein at Focal Contact 1237
Chuang, J.-Z., D.C. Lin, and S. Lin. 1995. Molecular cloning, expression, and
mapping of the high affinity actin-capping domain of chicken cardiac tensin.
J. Cell Biol. 128:1095Ð1109.
Crawford, A.W., and M.C. Beckerle. 1991. Purification and characterization of
zyxin, an 82,000-dalton component of adherens junctions. J. Biol. Chem. 266:
5847Ð5853.
De Arruda, M.V., S. Watson, C.-S. Lin, J. Leavitt, and P. Matsudaira. 1990.
Fimbrin is a homologue of the cytoplasmic phosphoprotein plasmin and has
domains homologous with calmodulin and actin gelatin protein. J. Cell Biol.
111:1064Ð1079.
Drenckhahn, D., M.C. Beckerle, K. Burridge, and J. Otto. 1988. Identification
and subcellular location of talin in various cell types and tissues by means of
(125I)vinculin overlay, immunoblotting, and immunocytochemistry. Eur. J.
Cell Biol. 46:513Ð522.
Elisei, R., D. Weightman, P. Kendall-Taylor, G. Vassart, and M. Ludgate. 1993.
Muscle autoantigens in thyroid-associated ophthalmopathy: the limits of
molecular genetics. J. Endocrinol. Invest. 16:533Ð540.
Endo, T., and T. Masaki. 1982. Molecular properties and functions in vitro of
chicken smooth-muscle a-actinin in comparison with those of striated-mus-
cle a-actinins. J. Biochem. (Tokyo). 92:1457Ð1468.
Fannon, A.M., and D.R. Colman. 1996. A model for central synaptic junctional
complex formation based on the differential adhesive specificities of the cad-
herins. Neuron. 17:423Ð434.
Fraser, A.B., E. Eisenberg, W.W. Kielley, and F.D. Carlson. 1975. The interac-
tion of heavy meromyosin and subfragment 1 with actin. Physical measure-
ments in the presence and absence of adenosine triphosphate. Biochemistry.
14:2207Ð2214.
Geiger, B. 1979. A 130K protein from chicken gizzard: its localization at the ter-
mini of microfilament bundles in cultured chicken cells. Cell. 18:193Ð205.
Geiger, B. 1983. Membrane-cytoskeleton interaction. Biochim. Biophys. Acta.
737:305Ð341.
Geiger, B. 1989. Cytoskeleton-associated cell contacts. Curr. Opin. Cell Biol.
1:103Ð109.
Geiger, B., and D. Ginsberg. 1991. The cytoplasmic domain of adherens-type
junctions. Cell Motil. Cytoskel. 20:1Ð6.
Geiger, B., T. Volk, and T. Volberg. 1985. Molecular heterogeneity of adherens
junctions. J. Cell. Biol. 101:1523Ð1531.
Gottardi, C.J., M. Arpin, A.S. Fanning, and D. Louvard. 1996. The junction-
associated protein, zonula occludens-1, localizes to the nucleus before the
maturation and during the remodeling of cell-cell contacts. Proc. Natl. Acad.
Sci. USA. 93:10779Ð10784.
Hartwig, J.H., and D.J. Kwiatkowski. 1991. Actin-binding proteins. Curr. Opin.
Cell Biol. 3:87Ð97.
Hata, Y., and T.C. Sdhof. 1995. A novel ubiquitous form of Munc-18 interacts
with multiple syntaxins. Use of the yeast two-hybrid system to study interac-
tions between proteins involved in membrane traffic. J. Biol. Chem. 270:
13022Ð13028.
Heath, J.P., and G.A. Dunn. 1978. Cell to substratum contacts of chick fibro-
blasts and their relation to the microfilament system: a correlated interfer-
ence-reflexion and high-voltage electron-microscope study. J. Cell Sci. 29:
197Ð212.
Imazumi, K., T. Sasaki, K. Takahashi, and Y. Takai. 1994. Identification of a
rabphilin-3A-interacting protein as GTP cyclohydrolase I in PC12 cells. Bio-
chem. Biophys. Res. Commun. 205:1409Ð1416.
Itoh, M., S. Yonehara, A. Nagafuchi, Sa. Tsukita, and Sh. Tsukita. 1991. A 220-
kD undercoat-constitutive protein: its specific localization at cadherin-based
cellÐcell adhesion sites. J. Cell Biol. 115:1449Ð1462.
Itoh, M., A. Nagafuchi, S. Moroi, and Sh. Tsukita. 1997. Involvement of ZO-1
in cadherin-based cell adhesion through its direct binding to a-catenin and
actin filaments. J. Cell Biol. 138:181Ð192.
Izzard, C.S., and L.R. Lochner. 1976. Cell-to-substrate contacts in living fibro-
blasts: an interference reflexion study with an evaluation of the technique. J.
Cell Sci. 21:129Ð159.
Jockusch, B.M., P. Bubeck, K. Giehl, M. Kroemker, J. Moschner, M. Rothke-
gel, M. Rdiger, K. Schlter, G. Stanke, and J. Winkler. 1995. The molecular
architecture of focal adhesions. Annu. Rev. Cell Dev. Biol. 11:379Ð416.
Kato, M., T. Sasaki, T. Ohya, H. Nakanishi, H. Nishioka, M. Imamura, and Y.
Takai. 1996. Physical and functional interaction of rabphilin-3A with a-acti-
nin. J. Biol. Chem. 271:31775Ð31778.
Keely, P., L. Parise, and R. Juliano. 1998. Integrins and GTPases in tumour cell
growth, motility, and invasion. Trends Cell Biol. 8:101Ð107.
Knudsen, K.A., A.P. Soler, K.R. Johnson, and M.J. Wheelock. 1995. Interac-
tion of a-actinin with the cadherin/catenin cellÐcell adhesion complex via
a-catenin. J. Cell Biol. 130:67Ð77.
Kotani, H., K. Takaishi, T. Sasaki, and Y. Takai. 1997. Rho regulates associa-
tion of both the ERM family and vinculin with the plasma membranes in
MDCK cells. Oncogene. 14:1705Ð1713.
Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the
head of bacteriophage T4. Nature. 227:680Ð685.
Lewis, J.M., R. Baskaran, S. Taagepera, M.A. Schwartz, and J.Y. Wang. 1996.
Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear
transport. Proc. Natl. Acad. Sci. USA. 93:15174Ð15179.
Lo, S.H., Q. An, S. Bao, W.-K. Wong, Y. Liu, P.A. Janmey, J.H. Hartwig, and
L.B. Chen. 1994. Molecular cloning of chick cardiac muscle tensin. J. Biol.
Chem. 269:22310Ð22319.
Luna, E.J., and A.L. Hitt. 1992. Cytoskeleton-plasma membrane interactions.
Science. 258:955Ð964.
Lupas, A. 1996. Coiled coils: new structures and new functions. Trends Bio-
chem. Sci. 21:375Ð382.
Lupas, A., M. Van Dyke, and J. Stock. 1991. Predicting coiled coils from pro-
tein sequences. Science. 252:1162Ð1164.
Mandai, K., H. Nakanishi, A. Satoh, H. Obaishi, M. Wada, H. Nishioka, M.
Itoh, A. Mizoguchi, T. Aoki, T. Fujimoto, et al. 1997. Afadin: a novel actin
filament-binding protein with one PDZ domain localized at cadherin-based
cell-to-cell adherens junction. J. Cell Biol. 139:517Ð528.
Matsudaira, P. 1991. Modular organization of actin crosslinking proteins.
Trends Biochem. Sci. 16:87Ð92.
Mizoguchi, A., S. Kim, T. Ueda, A. Kikuchi, H. Yorifuji, N. Hirooka, and Y.
Takai. 1990. Localization and subcellular distribution of smg p25A, a ras
p21-like GTP-binding protein, in rat brain. J. Biol. Chem. 91:257Ð269.
Molenaar, M., M. van de Wetering, M. Oosterwegel, J. Peterson-Maduro, S.
Godsave, V. Korinek, J. Roose, O. Destree, and H. Clevers. 1996. XTcf-3
transcription factor mediates b-catenin-induced axis formation in Xenopus
embryos. Cell. 86:391Ð399.
Nagafuchi, A., M. Takeichi, and Sh. Tsukita. 1991. The 102 kd cadherin-associ-
ated protein: similarity to vinculin and posttranscriptional regulation of ex-
pression. Cell. 65:849Ð857.
Nakai, K., and M. Kanehisa. 1992. A knowledge base for predicting protein lo-
calization sites in eukaryotic cells. Genomics. 14:897Ð911.
Nakanishi, H., H. Obaishi, A. Satoh, M. Wada, K. Mandai, K. Satoh, H. Ni-
shioka, Y. Matsuura, A. Mizoguchi, and Y. Takai. 1997. Neurabin: a novel
neural tissueÐspecific actin filamentÐbinding protein involved in neurite for-
mation. J. Cell Biol. 139:951Ð961.
Nix, D.A., and M.C. Beckerle. 1997. Nuclear-cytoplasmic shuttling of the focal
contact protein, zyxin: a potential mechanism for communication between
sites of cell adhesion and the nucleus. J. Cell Biol. 138:1139Ð1147.
Obaishi, H., H. Nakanishi, K. Mandai, K. Satoh, A. Satoh, K. Takahashi, M.
Miyahara, H. Nishioka, K. Takaishi, and Y. Takai. 1998. Frabin, a novel
FGD1-related actin filament-binding protein capable of changing cell shape
and activating c-Jun N-terminal kinase. J. Biol. Chem. 273:18697Ð18700.
Ozawa, M., H. Baribault, and R. Kemler. 1989. The cytoplasmic domain of the
cell adhesion molecule uvomorulin associates with three independent pro-
teins structurally related in different species. EMBO (Eur. Mol. Biol. Or-
gan.) J. 8:1711Ð1717.
Pardee, J.D., and J.A. Spudich. 1982. Purification of muscle actin. Methods En-
zymol. 85:164Ð181.
Pasteris, N.G., A. Cadle, L.J. Losie, M.E.M. Porteous, C.E. Shwarts, R.E.
Stevenson, T.W. Glover, R.S. Wilroy, and J.L. Gorski. 1994. Isolation and
characterization of the faciogenital dysplasia (Aarskog-Scott syndrome)
gene: a putative Rho/Rac guanine nucleotide exchange factor. Cell. 79:669Ð
678.
Pestonjamasp, K., M.R. Amieva, C.P. Strassel, W.M. Nauseef, H. Furthmayr,
and E.J. Luna. 1995. Moesin, ezrin, and p205 are actin-binding proteins asso-
ciated with neutrophil plasma membranes. Mol. Biol. Cell. 6:247Ð259.
Philp, N.J., M.Y. Yoon, and R.S. Hock. 1990. Identification and localization of
talin in chick retinal pigment epithelial cells. Exp. Eye Res. 51:191Ð198. 
Pollard, T.D., and J.A. Cooper. 1982. Methods to characterize actin filament
networks. Methods Enzymol. 85:211Ð233.
Rayment, I., H.M. Holden, M. Whittaker, C.B. Yohn, M. Lorenz, K.C. Holmes,
and R.A. Milligan. 1993. Structure of the actin-myosin complex and its impli-
cations for muscle contraction. Science. 261:58Ð65.
Rimm, D.L., E.R. Koslov, P. Kebriaei, C.D. Cianci, and J.S. Morrow. 1995.
a1(E)-catenin is an actin-binding and -bundling protein mediating the at-
tachment of F-actin to the membrane adhesion complex. Proc. Natl. Acad.
Sci. USA. 92:8813Ð8817.
Robbins, J., S.M. Dilworth, R.A. Laskey, and C. Dingwall. 1991. Two interde-
pendent basic domains in nucleoplasmin nuclear targeting sequence: identi-
fication of a class of bipartite nuclear targeting sequence. Cell. 64:615Ð623.
Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Labo-
ratory Manual. 2nd edition. Cold Spring Harbor Laboratory Press, Cold
Spring Harbor, NY.
Satoh, A., H. Nakanishi, H. Obaishi, M. Wada, K. Takahashi, K. Satoh, K.
Hirao, H. Nishioka, Y. Hata, A. Mizoguchi, and Y. Takai. 1998. Neurabin-II/
spinophilin: an actin filament-binding protein with one PDZ domain local-
ized at cadherin-based cell-cell adhesion sites. J. Biol. Chem. 273:3470Ð3475.
Schaller, M.D., C.A. Borgman, B.S. Cobbs, R.R. Vines, A.B. Reynolds, and
J.T. Parsons. 1992. pp125FAK: a structurally distinctive protein-tyrosine ki-
nase associated with focal adhesions. Proc. Natl. Acad. Sci. USA. 89:5192Ð
5196.
Schrder, R.R., D.J. Manstein, W. Jahn, H. Holden, I. Rayment, K.C. Holmes,
and J.A. Spudich. 1993. Three-dimensional atomic model of F-actin deco-
rated with Dictyostelium myosin S1. Nature. 364:171Ð174.
Schwartz, M.A., M.D. Schaller, and M.H. Ginsberg. 1995. Integrins: emerging
paradigms of signal transduction. Annu. Rev. Cell Dev. Biol. 11:549Ð599.
Takeichi, M. 1988. The cadherins: cell-cell adhesion molecules controlling ani-
mal morphogenesis. Development (Camb.). 102:639Ð655.
Takeichi, M. 1991. Cadherin cell adhesion receptors as a morphogenetic regula-
tor. Science. 251:1451Ð1455.
Takeuchi, M., Y. Hata, K. Hirao, A. Toyoda, M. Irie, and Y. Takai. 1997.
SAPAPs: a family of PSD-95/SAP90-associated proteins localized atThe Journal of Cell Biology, Volume 143, 1998 1238
postsynaptic density. J. Biol. Chem. 272:11943Ð11951.
Tidball, J.G., T. OÕHalloran, and K. Burridge. 1986. Talin at myotendinous
junctions.  J. Cell Biol. 103:1465Ð1472.
Tsukita, Sa., S. Yonemura, and Sh. Tsukita. 1997. ERM proteins: head-to-tail
regulation of actin-plasma membrane interaction. Trends Biochem. Sci. 22:
53Ð58.
Tsukita, Sh., Sa. Tsukita, A. Nagafuchi, and S. Yonemura. 1992. Molecular link-
age between cadherins and actin filaments in cell-cell adherens junctions.
Curr. Opin. Cell Biol. 4:834Ð839.
Turner, C.E., and K. Burridge. 1991. Transmembrane molecular assemblies in
cell-extracellular matrix interactions. Curr. Opin. Cell Biol. 3:849Ð853.
Turner, C.E., J. Glenney, Jr., and K. Burridge. 1990. Paxillin: a new vinculin-
binding protein present in focal adhesions. J. Cell Biol. 111:1059Ð1068.
Uchida, N., Y. Honjo, K.R. Johnson, M.J. Wheelock, and M. Takeichi. 1996.
The catenin/cadherin adhesion system is localized in synaptic junctions bor-
dering transmitter release zones. J. Cell Biol. 135:767Ð779.
Wang, E., H.L. Yin, J.G. Krueger, L.A. Caliguiri, and I. Tamm. 1984. Unphos-
phorylated gelsolin is localized in regions of cell-substratum contact or at-
tachment in Rous sarcoma virus-transformed rat cells. J. Cell Biol. 98:761Ð
771.
Wilkins, J.A., M.A. Risinger, and S. Lin. 1986. Studies on proteins that copurify
with smooth muscle vinculin: identification of immunologically related spe-
cies in focal adhesions of nonmuscle and Z-lines of muscle cells. J. Cell Biol.
103:1483Ð1494.
Yang, Y., J. Dowling, Q.C. Yu, P. Kouklis, D.W. Cleveland, and E. Fuchs. 1996.
An essential cytoskeletal linker protein connecting actin microfilaments to
intermediate filaments. Cell. 86:655Ð665.
Zheng, Y., D.J. Fisher, M.F. Santos, G. Tigyi, N.G. Pasteris, J.L. Gorski, and Y.
Xu. 1996. The faciogenital dysplasia gene product FGD1 functions as a
Cdc42Hs-specific guanine nucleotide exchange factor. J. Biol. Chem. 271:
33169Ð33172.